The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Sulforaphane as a Potential Protective Phytochemical against Neurodegenerative Diseases
Open accessAbstract
A wide variety of acute and chronic neurodegenerative diseases, including ischemic/traumatic brain injury, Alzheimer’s disease, and Parkinson's disease, share common characteristics such as oxidative stress, misfolded proteins, excitotoxicity, inflammation, and neuronal loss. As no drugs are available to prevent the progression of these neurological disorders, intervention strategies using phytochemicals have been proposed as an alternative form of treatment. Among phytochemicals, isothiocyanate sulforaphane, derived from the hydrolysis of the glucosinolate glucoraphanin mainly present in Brassica vegetables, has demonstrated neuroprotective effects in several in vitro and in vivo studies. In particular, evidence suggests that sulforaphane beneficial effects could be mainly ascribed to its peculiar ability to activate the Nrf2/ARE pathway. Therefore, sulforaphane appears to be a promising compound with neuroprotective properties that may play an important role in preventing neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ping, Z., Liu, W., Kang, Z., Cai, J., Wang, Q., Cheng, N., Wang, S., Wang, S., Zhang, J. H., & Sun, X. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.036 · Cited by 155
RetractedSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 1×
“These antioxidants and cytoprotective enzymes are regulated by a common mechanism that involves two proteins: nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like-ECH-associated protein 1 (Keap1) [49, 50].”
BackgroundCancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947 · cited 2×
“The brain is particularly vulnerable to oxidative stress because of its high oxygen consumption, high content of oxidizable polyunsatured fatty acids, and low antioxidant defense capacities especially in aging brains [32–34].”
BackgroundThe new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Moderate and severe traumatic brain injury in adults
Maas, A. I., Stocchetti, N., & Bullock, R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70164-9 · Cited by 2,123
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
The cytoprotective role of the Keap1–Nrf2 pathway
Baird, L., & Dinkova-Kostova, A. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0674-5 · Cited by 1,027
Traumatic Brain Injury: A Disease Process, Not an Event
Masel, B. E., & DeWitt, D. S. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1358 · Cited by 955
Mandelkow, E. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01368-3 · Cited by 953
Does oxidative damage to DNA increase with age?
Hamilton, M. L., Van Remmen, H., Drake, J. A., Yang, H., Guo, Z. M., Kewitt, K., Walter, C. A., & Richardson, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171202698 · Cited by 768
Effect of Plant Flavonoids on Immune and Inflammatory Cell Function
Middleton, E. (1998) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-5335-9_13 · Cited by 734
The Role of Markers of Inflammation in Traumatic Brain Injury
Woodcock, T., & Morganti-Kossmann, M. C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00018 · Cited by 712
Molecular basis for chemoprevention by sulforaphane: a comprehensive review
Juge, N., Mithen, R. F., & Traka, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6484-5 · Cited by 693
Glucosinolates and isothiocyanates in health and disease
Dinkova-Kostova, A. T., & Kostov, R. V. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.003 · Cited by 605
Talalay, P., De Long, M. J., & Prochaska, H. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8261 · Cited by 591
The unfolded protein response is activated in Alzheimer’s disease
Hoozemans, J. J. M., Veerhuis, R., Van Haastert, E. S., Rozemuller, J. M., Baas, F., Eikelenboom, P., & Scheper, W. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1038-0 · Cited by 551
Kraft, A. D., Johnson, D. A., & Johnson, J. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3817-03.2004 · Cited by 541
Prospects for new restorative and neuroprotective treatments in Parkinson's disease
Dunnett, S. B., & Björklund, A. (1999) · Nature · doi:10.1038/399a032 · Cited by 537
Direct and indirect antioxidant properties of inducers of cytoprotective proteins
Dinkova-Kostova, A. T., & Talalay, P. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700195 · Cited by 535
A Novel Mechanism of Chemoprotection by Sulforaphane
Myzak, M. C., Karplus, P. A., Chung, F.-L., & Dashwood, R. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1326 · Cited by 494
The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
Innamorato, N. G., Rojo, A. I., García-Yagüe, À. J., Yamamoto, M., de Ceballos, M. L., & Cuadrado, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.680 · Cited by 480
Shapiro, T. A., Fahey, J. W., Wade, K. L., Stephenson, K. K., & Talalay, P. (2001) · PubMed · Cited by 476
Involvement of ROS in BBB dysfunction
Pun, P. B. L., Lu, J., & Moochhala, S. (2009) · Free Radical Research · doi:10.1080/10715760902751902 · Cited by 457
Winiwarter, S., Bonham, N. M., Ax, F., Hallberg, A., Lennernäs, H., & Karlén, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9810102 · Cited by 453
The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease
Calkins, M. J., Johnson, D. A., Townsend, J. A., Vargas, M. R., Dowell, J. A., Williamson, T. P., Kraft, A. D., Lee, J.-M., Li, J., & Johnson, J. A. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2242 · Cited by 438
The neurophysiology of brain injury
Gaetz, M. (2004) · Clinical Neurophysiology · doi:10.1016/s1388-2457(03)00258-x · Cited by 399
Ritchie, K., & Lovestone, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11667-9 · Cited by 387
Transcriptional Regulation of the Antioxidant Response Element
Nguyen, T., Huang, H. C., & Pickett, C. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000361200 · Cited by 378
Spencer, J. P. E., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., & Halliwell, B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052112.x · Cited by 373 · cited 1×
“CysDA adducts have been reported in human brain tissue and are elevated in the brains of patients suffering from PD [114].”
BackgroundMitochondrial calcium and oxidative stress as mediators of ischemic brain injury
Starkov, A. A., Chinopoulos, C., & Fiskum, G. (2004) · Cell Calcium · doi:10.1016/j.ceca.2004.02.012 · Cited by 339
Shapiro, T. A., Fahey, J. W., Dinkova-Kostova, A. T., Holtzclaw, W. D., Stephenson, K. K., Wade, K. L., Ye, L., & Talalay, P. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5501_7 · Cited by 330
Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies
Bramlett, H. M., & Dietrich, W. D. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(06)61009-1 · Cited by 329
Jazwa, A., Rojo, A. I., Innamorato, N. G., Hesse, M., Fernández-Ruiz, J., & Cuadrado, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3731 · Cited by 327
Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2
Ma, Q., & He, X. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004333 · Cited by 317
Gasper, A. V., Al-janobi, A., Smith, J. A., Bacon, J. R., Fortun, P., Atherton, C., Taylor, M. A., Hawkey, C. J., Barrett, D. A., & Mithen, R. F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.6.1283 · Cited by 317
Manley, G. T., Binder, D. K., Papadopoulos, M. C., & Verkman, A. S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.088 · Cited by 312
Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli
Matusheski, N. V., Juvik, J. A., & Jeffery, E. H. (2004) · Phytochemistry · doi:10.1016/j.phytochem.2004.04.013 · Cited by 302
Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain Injury
Zhao, J., Moore, A. N., Redell, J. B., & Dash, P. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1683-07.2007 · Cited by 274
Health Effects and Bioavailability of Dietary Flavonols
Hollman, P. C. H., & Katan, M. B. (1999) · Free Radical Research · doi:10.1080/10715769900301351 · Cited by 272
Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Therapeutic Perspectives
Melo, A., Monteiro, L., Lima, R. M. F., de Oliveira, D. M., de Cerqueira, M. D., & El-Bachá, R. S. (2011) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2011/467180 · Cited by 249
Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents
Zhao, J., Kobori, N., Aronowski, J., & Dash, P. K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.065 · Cited by 245
Neuroprotective Strategies in Parkinson???s Disease: An Update on Progress
Mandel, S., Gr??nblatt, E., Riederer, P., Gerlach, M., Levites, Y., & Youdim, M. B. H. (2003) · CNS Drugs · doi:10.2165/00023210-200317100-00004 · Cited by 237
Defective ubiquitination of cerebral proteins in Alzheimer's disease
L�pez Salon, M., Morelli, L., Casta�o, E. M., Soto, E. F., & Pasquini, J. M. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20001015)62:2<302::aid-jnr15>3.0.co;2-l · Cited by 224
Interaction of dietary antioxidants in vivo: how fruit and vegetables prevent disease?
Eastwood, M. A. (1999) · QJM · doi:10.1093/qjmed/92.9.527 · Cited by 217
Egner, P. A., Chen, J. G., Wang, J. B., Wu, Y., Sun, Y., Lu, J. H., Zhu, J., Zhang, Y. H., Chen, Y. S., Friesen, M. D., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0296 · Cited by 208
Clarke, J. D., Hsu, A., Riedl, K., Bella, D., Schwartz, S. J., Stevens, J. F., & Ho, E. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.07.005 · Cited by 206
Kassahun, K., Davis, M., Hu, P., Martin, B., & Baillie, T. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970080t · Cited by 203
Li, J., Lee, J.-M., & Johnson, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109380200 · Cited by 193
Negi, G., Kumar, A., & S. Sharma, S. (2011) · Current Neurovascular Research · doi:10.2174/156720211798120972 · Cited by 183
Morroni, F., Tarozzi, A., Sita, G., Bolondi, C., Zolezzi Moraga, J. M., Cantelli-Forti, G., & Hrelia, P. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.03.004 · Cited by 179
Self-citationJakubíková, J., Sedlák, J., Mithen, R., & Bao, Y. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.015 · Cited by 175
Jin, W., Wang, H., Yan, W., Xu, L., Wang, X., Zhao, X., Yang, X., Chen, G., & Ji, Y. (2008) · Mediators of Inflammation · doi:10.1155/2008/725174 · Cited by 172
Metabolism and Tissue Distribution of Sulforaphane in Nrf2 Knockout and Wild-Type Mice
Clarke, J. D., Hsu, A., Williams, D. E., Dashwood, R. H., Stevens, J. F., Yamamoto, M., & Ho, E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0500-z · Cited by 168
Zhao, J., Moore, A. N., Clifton, G. L., & Dash, P. K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20649 · Cited by 167
Trinh, K., Moore, K., Wes, P. D., Muchowski, P. J., Dey, J., Andrews, L. A., & Pallanck, L. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4778-07.2008 · Cited by 165
Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal model
Kim, H. V., Kim, H. Y., Ehrlich, H. Y., Choi, S. Y., Kim, D. J., & Kim, Y. S. (2012) · Amyloid · doi:10.3109/13506129.2012.751367 · Cited by 163
Kwak, M.-K., Cho, J.-M., Huang, B., Shin, S., & Kensler, T. W. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.029 · Cited by 157
Zhang, Y., & CALLAWAY, E. C. (2002) · Biochemical Journal · doi:10.1042/bj3640301 · Cited by 150
Sulforaphane improves cognitive function administered following traumatic brain injury
Dash, P. K., Zhao, J., Orsi, S. A., Zhang, M., & Moore, A. N. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.028 · Cited by 148
Soriano, F. X., Léveillé, F., Papadia, S., Higgins, L. G., Varley, J. A., Baxter, P. S., Hayes, J. D., & Hardingham, G. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05648.x · Cited by 146
Protective Effect of Sulforaphane against Dopaminergic Cell Death
Han, J. M., Lee, Y. J., Lee, S. Y., Kim, E., Moon, Y., Kim, H. W., & Hwang, O. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110866 · Cited by 146
Gan, N., Wu, Y.-C., Brunet, M., Garrido, C., Chung, F., Dai, C., & Mi, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152686 · Cited by 144
Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease
Lee, P., Bordelon, Y. M., Bronstein, J. M., & Ritz, B. R. (2012) · Neurology · doi:10.1212/wnl.0b013e3182749f28 · Cited by 143
Danilov, C. A., Chandrasekaran, K., Racz, J. L., Soane, L., Zielke, C. L., & Fiskum, G. M. (2008) · Glia · doi:10.1002/glia.20793 · Cited by 142
hMAF, a Small Human Transcription Factor That Heterodimerizes Specifically with Nrf1 and Nrf2
Marini, M. G., Chan, K., Casula, L., Kan, Y. W., Cao, A., & Moi, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16490 · Cited by 140
Chen, G., Fang, Q., Zhang, J., Zhou, D., & Wang, Z. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22577 · Cited by 138
Hong, Y., Yan, W. X., Chen, S., Sun, C., & Zhang, J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.101 · Cited by 138
Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
Farooqui, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6652-0 · Cited by 136
Mitochondrial peroxiredoxin‐3 protects hippocampal neurons from excitotoxic injury in vivo
Hattori, F., Murayama, N., Noshita, T., & Oikawa, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01918.x · Cited by 133
Duffy, S. N., So, A., & Murphy, T. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010069.x · Cited by 133
Brain mitochondrial dysfunction and oxidative damage in Parkinson’s disease
Navarro, A., & Boveris, A. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9250-6 · Cited by 130
Brain Ventricular Volume and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Ott, B. R., Initiative, T. A. D. N., Cohen, R. A., Gongvatana, A., Okonkwo, O. C., Johanson, C. E., Stopa, E. G., Donahue, J. E., & Silverberg, G. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1406 · Cited by 128
Parkinson's disease and Alzheimer disease: environmental risk factors
Campdelacreu, J. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2012.04.022 · Cited by 118
Modulation of Phase II Enzymes by Sulforaphane: Implications for Its Cardioprotective Potential
Angeloni, C., Leoncini, E., Malaguti, M., Angelini, S., Hrelia, P., & Hrelia, S. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf900549c · Cited by 117
Self-citationTarozzi, A., Morroni, F., Merlicco, A., Hrelia, S., Angeloni, C., Cantelli‐Forti, G., & Hrelia, P. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06394.x · Cited by 117
Self-citationEvaluation of the Potential for Olestra To Affect the Availability of Dietary Phytochemicals ,
Cooper, D. A., Webb, D., & Peters, J. C. (1997) · Journal of Nutrition · doi:10.1093/jn/127.8.1699s · Cited by 117
Spencer, J. P. E., Whiteman, M., Jenner, P. G., & Halliwell, B. B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00808.x · Cited by 111
Tarozzi, A., Morroni, F., Merlicco, A., Bolondi, C., Teti, G., Falconi, M., Cantelli‐Forti, G., & Hrelia, P. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.006 · Cited by 106
Self-citationVauzour, D., Ravaioli, G. M., Vafeiadou, K., Rodriguez‐Mateos, A., Angeloni, C., & Spencer, J. P. E. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.011 · Cited by 99
Self-citationTannenberg, R. K., Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.05.004 · Cited by 96
Mizuno, K., Kume, T., Muto, C., Takada‐Takatori, Y., Izumi, Y., Sugimoto, H., & Akaike, A. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10257fp · Cited by 96
Siebert, A. A., Desai, V., Chandrasekaran, K., Fiskum, G. M., & Jafri, M. S. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21975 · Cited by 96
The Unfolded Protein Response Protects from Tau Neurotoxicity In Vivo
Loewen, C. A., & Feany, M. Β. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013084 · Cited by 95
Soane, L., Dai, W. L., Fiskum, G. M., & Bambrick, L. L. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22307 · Cited by 93
Neuroprotective Effects of Sulforaphane after Contusive Spinal Cord Injury
Benedict, A. L., Mountney, A., Hurtado, A., Bryan, K. E., Schnaar, R. L., Dinkova‐Kostova, A. T., & Talalay, P. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2474 · Cited by 93
Vauzour, D., Buonfiglio, M., Corona, G., Chirafisi, J., Vafeiadou, K., Angeloni, C., Hrelia, S., Hrelia, P., & Spencer, J. P. E. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900197 · Cited by 88
Self-citationMelchini, A., Costa, C., Τράκα, Μ., Miceli, N., Mithen, R. F., Pasquale, R. D., & Trovato, A. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.03.024 · Cited by 87
Yao, J., Taylor, M., Davey, F. D., Ren, Y., Aiton, J., Coote, P. J., Fang, F., Chen, J. X., Yan, S. D., & Gunn‐Moore, F. J. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.03.013 · Cited by 85
Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome
Park, H.-M., Kim, J., & Kwak, M. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1124-2 · Cited by 81
Enhanced NAD(P)H:Quinone Reductase Activity Prevents Glutamate Toxicity Produced by Oxidative Stress
Murphy, T. H., Long, M. J., & Coyle, J. T. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02019.x · Cited by 79
Greco, T., & Fiskum, G. M. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9312-9 · Cited by 68
Environmental Risk Factors for Parkinson's Disease: The Epidemiologic Evidence
Schoenberg, B. S. (1987) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037811 · Cited by 62
Porritt, M. J., Andersson, H. C., Hou, L., Nilsson, A. E., Pekna, M., Pekny, M., & Nilsson, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041090 · Cited by 61
Peroxiredoxin 2 ( PRDX2 ), an antioxidant enzyme, is underexpressed in Down syndrome fetal brains
Sánchez-Font, M. F., Sebasti�, J., Sanfeliu, C., Crist�fol, R., Marfany, G., & Gonz�les-Duarte, R. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3048-1 · Cited by 57
Jin, H. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.731 · Cited by 56
Boulos, S., Meloni, B. P., Arthur, P. G., Bojarski, C., & Knuckey, N. W. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21429 · Cited by 55
Srivastava, S., Alfieri, A., Siow, R. C. M., Mann, G. E., & Fraser, P. A. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.257964 · Cited by 51
Inhibition of the formation of the neurotoxin 5-S-cysteinyl-dopamine by polyphenols
Vauzour, D., Vafeiadou, K., & Spencer, J. P. E. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.153 · Cited by 44
From Brain Ischemia-Reperfusion Injury to Possible Sporadic Alzheimers Disease
Pluta, R. M. (2004) · Current Neurovascular Research · doi:10.2174/1567202043361839 · Cited by 42
Tarozzi, A., Morroni, F., Bolondi, C., Sita, G., Hrelia, P., Djemil, A., & Cantelli‐Forti, G. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130910899 · Cited by 42
Self-citationLee, S. Y., Moon, Y., Choi, D. H., Choi, H. J., & Hwang, O. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.024 · Cited by 41
Protective effects of isothiocyanates on blood-CSF barrier disruption induced by oxidative stress
Xiang, J., Alesi, G. N., Zhou, N., & Keep, R. F. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00518.2011 · Cited by 37
Sulforaphane protects SK‐N‐SH cells against antipsychotic‐induced oxidative stress
Mas, S., Gassó, P., Trias, G., Bernardo, M., & Lafuente, A. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00988.x · Cited by 23
Inactivation of Aconitase by Tetrahydrobiopterin in DArgic Cells: Relevance to PD
Yoon, N. S., Cho, Y., Lee, S. Y., Choi, H. J., & Hwang, O. (2010) · Experimental Neurobiology · doi:10.5607/en.2010.19.1.23 · Cited by 14
Detecting bioactive amyloid β peptide species in Alzheimer's disease
Liu, Y., Dargusch, R., Banh, C., Miller, C. A., & Schubert, D. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02751.x · Cited by 12
Cited by
Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485089 · Cited by 2,127
Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Sivandzade, F., Prasad, S., Bhalerao, A., & Cucullo, L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.11.017 · Cited by 639
Activators and inhibitors of NRF2: a review of their potential for clinical development
Robledinos-Antón, N., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9372182 · Cited by 413
Subedi, L., Lee, J., Yumnam, S., Ji, E., & Kim, S. (2019) · Cells · doi:10.3390/cells8020194 · Cited by 271
Metadata
- Authors
- Tarozzi, A., Angeloni, C., Malaguti, M., Morroni, F., Hrelia, S., & Hrelia, P.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-10
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2133783484
- Cited by
- 282
- References
- 117
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.